NovaMedica Inks Pact to Build $85 Million Facility, 100 New Jobs Will be Created

Print 26 July 2013
BioSpace

The Government of Kaluga Region, the Administrative Board of the City of Kaluga and NovaMedica pharmaceutical company (a subsidiary of RUSNANO and Domain Associates) have signed an agreement on the execution of an investment project to build a new pharmaceutical plant in the region.

The document was signed by Anatoly Artamonov, Governor of Kaluga Region, Nikolay Polezhaev, Mayor of the City of Kaluga, Nikolay Milkis, General Director of the Kaluga Region Development Corporation, and Vladimir Gurdus, General Director of D-Pharma, which is managing the NovaMedica project.

The new plant will be built under a joint venture between Domain Associates LLC, one of the leading American venture capital funds, which specializes in pharmaceuticals, and RUSNANO, a Russian government-owned investment company. 

Return